{"id":"W3029182802","doi":"10.1016/j.ejca.2020.04.015","title":"Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Immunocore; Merck Sharp and Dohme; Sandoz; Bristol-Myers Squibb Canada; Genentech; SkylineDx; EORTC Charitable Trust; Sun Pharma; Sysmex Corporation; Pfizer; InflaRx; European Organisation for Research and Treatment of Cancer; Les Laboratories Pierre Fabre; Swedish Orphan Biovitrum; Array BioPharma; Roche; Regeneron Pharmaceuticals; Novartis; Sanofi; GlaxoSmithKline; Merck; Bayer; AstraZeneca; Amgen","keywords":"Medicine; Adjuvant; Pegylated interferon; Internal medicine; Stage (stratigraphy); Oncology; Adjuvant therapy; Cancer; Immunology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007466828,0.0001220556,0.0003526616,0.0001054421,0.00006232007,0.00001478126,0.00008520851,0.00001320826,0.00003880349],"category_scores_gemma":[0.00006618984,0.00006462109,0.00004694699,0.0002562315,0.00007488752,0.00005843849,0.00002368982,0.0001332897,2.385033e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001967202,"about_ca_system_score_gemma":0.0001729791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008073728,"about_ca_topic_score_gemma":0.0001212163,"domain_scores_codex":[0.9981897,0.0005337146,0.0005918116,0.0001579545,0.0004026814,0.0001241461],"domain_scores_gemma":[0.9985492,0.00006119626,0.0006035301,0.0001282307,0.0005818899,0.00007599608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9067316,0.0005497532,0.01378056,0.0000763181,0.0004091924,0.00003585148,0.006332857,0.0003761069,0.01253112,0.00000202059,0.0003981052,0.05877653],"study_design_scores_gemma":[0.5695772,0.05173035,0.3491696,0.0005515635,0.0001725398,0.000004017169,0.0004050172,0.0001407169,0.01217025,0.000001100895,0.01595206,0.0001255468],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954432,0.0002385889,0.000055454,0.001755562,0.0001072991,0.001787653,0.00003386433,0.000006226556,0.0005721796],"genre_scores_gemma":[0.9984118,0.0006120332,0.0000867162,0.0001365548,0.0001700389,0.00001014196,0.0000107401,0.00003636241,0.0005256045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3371544,"threshold_uncertainty_score":0.2635171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07156594054221829,"score_gpt":0.3098397527023926,"score_spread":0.2382738121601743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}